Orin
CPBNasdaq·Packaged Foods

Campbell Soup Company

Market cap $6.2BP/E 15.4× trailingGross margin 28.1%Reports Tue 8 Dec, before the open
$20.68
+0.05 (+0.24%)Tue 27 Oct close 16:00 ET
52-wk $18.60 – $32.04
Orin's take
6out of 10 — how sure Orin is of this read

Orin's own judgment of how firmly the evidence points one way — not the chance the price goes up.

Refreshed 8 Oct, the 12th take on CPB. A new filing or a print queues the next refresh.

Campbell's has been heavily punished — down 16% in September to $18.90 as of 7 Oct — after FY2026 (ended 2 Aug) results confirmed severe deterioration with full-year EPS falling 34.8% to $1.31 and Q4 delivering just $4M in operating income alongside a $60M net loss.

The 35.9% dividend cut, while a negative signal, is a necessary deleveraging step given $7.14B in total debt against $3.85B in equity, and FY27 guidance for organic sales down 4%-2% and adjusted EPS down 24%-17% signals near-term headwinds persist. With RSI at 31 (deeply oversold), a PS multiple of 0.58x (23.4% below the peer median), and FCF of $678M still intact, much of the bad news appears priced in, but margin stabilization and a return to revenue growth must materialize before a constructive stance is warranted.

What could go wrong

  • Margin compression continues. Gross margin fell to 28.1% in FY2026 from 30.4% in FY2025, and operating margin collapsed to 8.7% from 13.2%; continued inflation and negative pricing per FY27 guidance could drive further erosion.
  • Elevated leverage. Total debt of $7.14B against stockholders' equity of $3.85B and EV/EBITDA of 9.79x (157.4% above the peer median of 3.80x) constrain financial flexibility.
  • FY27 guidance implies further weakness. Management guided organic net sales down 4%-2% and adjusted EPS down 24%-17% for FY27, with gross margins pressured by inflation and negative pricing.
  • Insider disposition activity. Over 24 months, net insider selling of 14,150 shares ($394.5K net value), including a large disposition by vanBeuren of 437,692 shares to zero ownership.

What would change my mind

Margin stabilization. Gross margin recovery above 30% on a trailing-quarter basisbullish
Revenue return to growth. Quarterly revenue turns positive YoY after four consecutive quarters of declinebullish
Debt reduction progress. Total debt declines meaningfully below $7B with FCF-directed paydownbullish
Further guidance cuts. FY27 guidance is revised lower or Q1 FY27 results show accelerating margin declinebearish

Where this comes from: FY26 fundamentals · Q4 FY26 results · news, 5 Oct · technicals, 7 Oct. Orin's read on CPB; not advice.

How has the share price moved?

27 Oct 2025 – 27 Oct 2026

Down 34.1% over twelve months, from $31.39 on 27 Oct 2025 to $20.68 at the Tue 27 Oct 2026 close. Its highest close in that time was $31.66 on 21 Nov 2025; the last close is 34.7% below it.

Jan 2026AprJulOct
    • Green line: the closing price each trading day.
    • Grey line: the average closing price over the last 50 trading days.
    • Dashed amber line: the same over the last 200 trading days — a slower, smoother line.
    • Bars along the bottom: shares traded each day — green when it closed higher than the day before, rose when lower (the most, 62.1M, on 18 Jun 2026).
    • Flags: the company's filings, on the day they were made (a 10-Q is the quarterly report and a 10-K the annual report; an 8-K reports a major event).

    Largest holders · 13F Q2 2026

    Money flow
    FilerPositionOf fund
    BlackRock$650.8M0.0%
    Vanguard Portfolio Management$276.6M0.0%
    Vanguard Capital Management$206.1M0.0%
    Two Sigma Investments$179.2M0.1%
    State Street$173.3M0.0%
    Morgan Stanley$157.6M0.0%
    Goldman Sachs Group$110.1M0.0%
    Geode Capital Management$93.4M0.0%
    AQR Capital Management$90.7M0.0%
    Bank of New York Mellon$79.1M0.0%

    72 of the 815 filers we track · quarter ended Q2 2026 · positions, not flows

    Insiders, last 24 months: 135 Form 4 filings; open-market trades net −$395K. Of the 50 on hand, none was an open-market trade — the rest are grants, option exercises and tax withholding.

    Ask Orin about CPB

    its filings · its transcripts · its numbers

    Orin answers questions about CPB from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

    Start 3 free days →

    How is it priced, against its own past and its sector?

    Tue 27 Oct close

    Priced at 15.4× its last 12 months of profit (Tue 27 Oct close) — lower than in all 5 of its last 5 fiscal years (middle 16.7×); the typical Consumer Defensive company on the NASDAQ is at 37.9×.

    MeasureNowIts usualSector
    P/E15.4×below usual16.7×37.9×
    P/S0.63×below usual1.46×—
    EV/EBITDA10.1×below usual10.9×—
    P/B1.6×below usual3.7×—
    • "Its usual" is the middle of its own last 5 fiscal years.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    P/S: the company's total market value divided by one year of revenue. Used when there is no profit to measure.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    P/B: the share price divided by the book value per share — what the company owns minus what it owes, as its accounts record it. When book value is tiny, P/B swings wildly and says little.

    What do the analysts who cover it publish?

    18 firms rated it in the last 18 months · 27 Oct

    The analysts' average 12-month price target is $19.70 (from $18 to $22) — 5% below the Tue 27 Oct close price. That is their published opinion, not Orin's.

    Average price target

    $19.70

    $18 – $22 · −5% against the last close

    Their ratings
    • 0 buy or overweight
    • 11 hold
    • 7 underweight or sell

    Price target: the share price an analyst publishes for about 12 months ahead. It is the opinion of the firm that wrote it; the average is across the firms that cover the company.

    Overweight / underweight: analysts' rating words: overweight means the firm expects the stock to do better than the others it covers, underweight worse. Their words, not Orin's.

    How is it priced next to the companies it is compared to?

    2 of 5 with a profit

    Priced at 15.4× its last 12 months of profit. Only 2 of the 5 companies it is compared to made a profit (HRL 33.1×, SJM 59.3×), so there is no typical P/E.

    CompanyMarket valueP/EEV/EBITDAGross marginNet marginROE
    CPBCampbell Soup Company$6B15.4×10.1×28.1%4.1%10%
    CAGConagra Brands, Inc.$7Blost moneyn/m23.8%−17.0%−26%
    GISGeneral Mills, Inc.$18Blost money9.3×33.6%−4.9%−11%
    HRLHormel Foods Corporation$11B33.1×15.5×15.7%2.8%4%
    KHCThe Kraft Heinz Company$30Blost moneyn/m33.5%−14.0%−9%
    SJMThe J. M. Smucker Company$14B59.3×15.3×38.7%2.5%4%
    • CAG, GIS, KHC: lost money over the last 12 months, so no P/E.
    • CAG, KHC: EV/EBITDA is not meaningful (n/m) — its cash exceeds its market value plus debt, or the business lost money before depreciation.
    • The list of companies is the data vendor's choice, so it can include a company a person would not have picked.

    Market value: the share price times the number of shares — what the whole company is priced at.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    Gross margin: the share of each $1 of sales left after the direct cost of making what was sold.

    Net margin: the share of each $1 of sales kept as profit after every cost. Below zero, the company lost money.

    ROE: return on equity: one year of profit as a share of the shareholders' money in the business (its book value).

    Is it priced high or low compared with its own past?

    Tue 27 Oct

    Priced at 15.4× its last 12 months of profit (Tue 27 Oct close). It has no full fiscal year on file since its history starts, so there is nothing of its own to compare with.

    • Now15.4×

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    Fiscal year (FY): the company's own 12-month accounting year, which need not match the calendar year.

    How has its sector been priced?

    Now–Now · Tue 27 Oct

    Consumer Defensive companies on the NASDAQ were priced at a typical 37.9× their yearly profit (Tue 27 Oct close).

    • Now37.9×
    • Each year is the middle of that calendar year's daily sector P/E; "Now" is the Tue 27 Oct close figure, the same one in the table above.

    Sector P/E: the middle P/E of the companies in the same sector on the same stock exchange, as the data vendor works it out each day.

    What does a cash-flow model say a share is worth?

    computed 27 Oct at $20.35

    A standard cash-flow model puts it at $45 a share — 120% above the $20.35 price it was computed against (27 Oct).

    ModelValue a shareAgainst the price then
    Standard$45120% above $20.35
    Levered$3574% above $20.35

    Discounted cash flow: a model's estimate of what the company is worth today, from the cash it is forecast to make in future years. Small changes in the forecast move it a lot, and it says little about a company that loses money.

    Standard / levered: two versions of the cash-flow model: the standard one counts the cash before the company pays its lenders, the levered one after.